Bluejay DiagnosticsBJDX
13F holders, Q2 2025 (June 30)5holders +1
2new positions
1sold out
$1.72avg. 13F price*
At the end of Q2 2025, 5 institutions reported holding Bluejay Diagnostics Inc. (BJDX) in their 13F filings, up 1 from Q1 2025. 2 opened new positions and 1 sold out. The largest holders were Sabby Management, LLC ($165K), Tower Research Capital LLC (TRC) ($4K) and UBS Group AG ($764).
- Company
- Bluejay Diagnostics Inc.
- CUSIP
- 095633509
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $166K |
| Exits | 1 | $75 |
All 13F filers, Q1 2025 → Q2 2025: 96,808 shares bought and 388 shares sold, net +96,420 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Sabby Management, LLC | 1.34% | New | 96,033 | $165K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +30.6% | 2,272 | $4K |
| UBS Group AG | 0.00% | Reduce -45.3% | 444 | $764 |
| Citigroup Inc. | 0.00% | New | 241 | $415 |
| Bank of America Corp. | 0.00% | Add +25.0% | 5 | $9 |
"% of holder's portfolio" is BJDX's weight in each manager's 13F, not the share of Bluejay Diagnostics Inc. the manager owns.